🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This early access program will be conducted to provide access to Lazertinib...
Status
Approved For Marketing
Location
Multiple Locations
Start Date
TBD
Trial ID
NCT04829422
Treatments Being Tested
AMAZE-lung is a multicenter single-arm phase II trial. The protocol treatme...
Status
Active Not Recruiting
Location
Chu Angers
Start Date
2023-03-27
Trial ID
NCT05601973
Treatments Being Tested
In the randomized, multicenter Phase II clinical trial, we aim to evaluate ...
Status
Active Not Recruiting
Location
Severance hospital
Start Date
2022-02-07
Trial ID
NCT06268210
Treatments Being Tested
This trial is Phase II Trial of Lazertinib+Pemetrexed/Carboplatin in Patien...
Status
Active Not Recruiting
Location
Yonsei University Health System, Severance Hospital
Start Date
2023-04-07
Trial ID
NCT05786430
Treatments Being Tested
The purpose of the study is to simplify amivantamab intravenous administrat...
Status
Active Not Recruiting
Location
City of Hope Duarte
Start Date
2022-08-05
Trial ID
NCT05388669
* In this study, we hypothesized that immune engagement by amivantamab will...
Status
Not Yet Recruiting
Location
Multiple Locations
Start Date
2026-04-06
Trial ID
NCT07507188
Treatments Being Tested
Lazertinib is an oral third-generation irreversible tyrosine kinase inhibit...
Status
Unknown
Location
Yonsei University Health System, Severance Hospital
Start Date
2023-09
Trial ID
NCT06020989
Treatments Being Tested
This Phase III study will be conducted to evaluate the efficacy and safety ...
Status
Completed
Location
Princess Alexandra Hospital
Start Date
2020-02-13
Trial ID
NCT04248829
The purpose of this study is to assess the efficacy of the amivantamab and ...
Status
Active Not Recruiting
Location
Arizona Oncology Associates, PC - HAL
Start Date
2020-09-30
Trial ID
NCT04487080
Treatments Being Tested
This is a phase II, single-arm, multicenter trial, conducted through Latin ...
Status
Completed
Location
Pronutrir - Oncologia e Nutrição
Start Date
2023-05-24
Trial ID
NCT05299125
Treatments Being Tested